View / Download pdf version of this article
Most patients with acute upper or lower RTI symptoms do not benefit from antibiotics and prescribing antibiotics inappropriately
for these patients leads to unnecessary cost, adverse effects and the development of antibiotic resistance. Decades of
observational and interventional studies involving thousands of patients have, however, identified subgroups of patients
with conjunctivitis, sinusitis, sore throat and acute cough for whom antibiotics should be considered, based on the presence
of key features in their history, examination or laboratory test results (see: “Antibiotics:
choices for common infections”).. These features may not be evident when the patient first presents to the general practice clinic,
but may develop in the subsequent days to weeks. Options to capture this group of patients include immediate prescription
of antibiotics to all patients, a delayed prescription that can be used later if it becomes necessary, scheduling a follow-up
consultation or phone call, and no prescription of antibiotics (the patient may return for reassessment later if new symptoms
There are many factors that may contribute to the decision to offer a delayed prescription for a patient with a RTI,
including concerns about the potential for symptoms to worsen significantly in a patient with co-morbidities, previous
history of complications with RTIs, patient expectations and socioeconomic aspects such as the likelihood of the patient
being able to return for a consultation if their condition deteriorates. Examples of the pros and cons of the delayed
prescription strategy are listed in the box below.
The goals of delayed antibiotic prescription are to minimise antibiotic use for conditions in which an antibiotic has
little or no benefit, to have no negative effect on symptom duration or rate of serious complications, to provide patient
satisfaction and to positively influence patients’ future expectations around antibiotic treatments. A number of studies
have now evaluated delayed antibiotic strategy with these goals in mind.
Pros and cons of delayed antibiotic prescribing1
|May reduce antibiotic use and therefore reduce adverse effects and antibiotic resistance (compared with receiving an immediate prescription)
||May increase antibiotic use and therefore increase adverse effects and antibiotic resistance (if the antibiotic isused)
|Safety net if more severe symptoms and signs develop
||Risk that patient may fill the prescription regardless of their symptoms or for the wrong reasons
|Fulfils expectations for some patients and maintains the clinician-patient relationship
||Risk that patient may use the prescription inappropriately at a later date or for another family member
|Empowers the patient to be actively involved in their treatment
||May confuse messages about antibiotic stewardship
|Reduces costs and time for the patient of having to re-consult
||Instructions on using a delayed prescription may not be correctly understood or remembered by the patient if not
communicated effectively by the prescriber
|Allows control of factors such as the “Friday consultation”, upcoming travel or important events
||May result in negative perception of the clinician’s competence
|Reserves the use of antibiotics for more severe RTIs
||Serious illness or complications may be missed at the first consultation, or patients who later develop serious illness
or complications will collect the antibiotic prescription but might have been better re-consulting a doctor and receiving
more comprehensive treatment, e.g. hospitalisation
What percentage of patients fill delayed antibiotic prescriptions?
It is estimated that up to 50% of patients given a delayed prescription for an antibiotic will
collect their prescription.
A 2013 Cochrane systematic review compared delayed antibiotic prescribing versus immediate or no antibiotics in patients
with a RTI.2 Patients who were managed with a delayed prescribing strategy took fewer antibiotics (32%) than
patients who were prescribed an antibiotic immediately (93%).2 Patients who were not initially prescribed
an antibiotic had the lowest level of subsequent antibiotic use (14%).2
A randomised controlled trial published after the Cochrane review found that 33 – 39% of patients given a delayed antibiotic
prescription subsequently filled their prescription.3 The study involved 889 patients who presented to primary
care in the United Kingdom with an acute RTI. The 556 patients not judged to require immediate antibiotics were randomised
to one of four delayed prescribing strategies (“re-contact” the practice by phone to request a prescription, “post-dated”
prescription, placement of prescription at reception for “collection” and giving the patient a prescription with advice
to delay – “patient led”) or a “no prescribing” strategy. It is not clear what criteria the patients were advised for
filling their prescription. No significant differences were found between the four delayed strategies in the percentage
of patients who filled their prescription; 26% of patients who were not offered a prescription subsequently returned for
re-consultation and filled an antibiotic prescription.3
A New Zealand study, which was included in the 2013 Cochrane review, found that just under half of patients given a
delayed prescription took an antibiotic. The study randomised patients with an upper RTI presenting to a general practice
clinic in Auckland, who requested antibiotics or were perceived to want antibiotics, to receive either an immediate prescription
for an antibiotic or a delayed prescription with instructions to fill it after three days if their symptoms did not improve.
It was found that 89% of the 62 patients who were given an immediate prescription used the antibiotic, compared to 48%
of the 67 patients given a delayed prescription.4
Does delayed antibiotic prescribing lead to good clinical outcomes for patients?
Patients who take an antibiotic for a RTI are unlikely to shorten the duration of their symptoms, but they may
be less likely to experience suppurative complications; however, the development of complications in a patient with an
acute RTI, regardless of antibiotic use, is relatively uncommon.
It is probably not possible to demonstrate a difference in clinical outcome for antibiotic strategies in patient populations
who are unlikely to benefit from antibiotics in the first place. It is not surprising, therefore, that there was no difference
in symptom duration between patients randomised to delayed antibiotic prescribing versus no antibiotic in a population
of patients with mostly upper respiratory tract infections and sore throats,3 and in a population of patients
with uncomplicated lower respiratory tract infections.5 At least two studies, however, have detected a possible
reduction in complications in patients assigned to delayed antibiotic prescription versus no antibiotic. In the primary
care trial where patients were randomised to different antibiotic prescribing strategies, complications of RTI were experienced
by 1.5% of patients who received a delayed prescription compared to 2.5% of patients who were given an antibiotic immediately
and 2.5% of patients not given an antibiotic (not statistically significant).3 In a non-randomised cohort
study of 12677 patients with sore throat, the risk of complications was 0.58-fold in patients who used an antibiotic compared
to those who did not (adjusted risk ratio 0.34-0.98).6 The overall rate of suppurative complications observed
among the patients in this study was 1.4%; otitis media (0.6%) quinsy (0.4%), sinusitis (0.3%), impetigo or cellulitis
(0.2%).6 Although the supportive evidence for this is not strong, prevention of late complications is a key
goal of providing a delayed prescription to low-risk patients.
There was no measureable difference in adverse effects reported between patients using delayed
and no antibiotic strategies.3, 5 Antibiotic resistance rates were not measured.
Does delayed antibiotic prescribing help meet patient expectations and improve the clinician-patient relationship?
Patients who do not receive an antibiotic for a RTI are just as satisfied as those who do, provided that the
reasons for not prescribing an antibiotic are effectively explained.
There is evidence that patients expect antibiotic prescriptions less often than physicians believe they do, and patient
satisfaction is not reduced when the reasons for not prescribing an antibiotic are effectively communicated, including
reassurance that an antibiotic is not always appropriate or effective.7 It has also been reported that a
patient’s satisfaction scores are more strongly associated with receiving understandable information and reassurance than
actually receiving an antibiotic prescription.8
This is supported by the findings of the Cochrane review. Overall, patient satisfaction was high with immediate (92%),
delayed (87%) and no prescription (83%) strategies, with no significant differences in satisfaction between patients managed
using the delayed or no antibiotic prescribing strategies.2 In the primary care trial of antibiotic prescribing
strategies, there were also no significant differences found in satisfaction between patients who did not receive an antibiotic
(79% very satisfied) versus patients who were managed using the delayed antibiotic strategies (74 – 89%).3
In a New Zealand study of perceptions about delayed antibiotic prescriptions, it was found that patients were not as
concerned about being involved in decision-making about their health care as their clinicians perceived them to be.1 Most
patients preferred their clinician to decide whether they needed an antibiotic.1 Some clinicians believed
that offering a delayed antibiotic prescription would help the clinician to cope with the pressure to prescribe an antibiotic
for a RTI and be favourably received by the patient, act to reassure the patient and prevent them from visiting another
clinician for a prescription. However, the converse view was that by not making a decision about whether the patient needed
an antibiotic, the patient may perceive the doctor to be incompetent.1
Patient satisfaction is strongly linked to patient expectations.8 Patient expectations may be unreasonable,
however, such as when a patient expects an antibiotic despite lack of evidence for benefit in that condition and in the
face of increasing antibiotic resistance. Patient satisfaction should not be the only goal of the clinician-patient interaction
but can hopefully be maintained in those not given an immediate antibiotic prescription by reassurance, positive advice
on symptom-relief, and a strategy for identifying if a patient’s condition is deteriorating.
Does delayed antibiotic prescribing help educate patients and improve future expectations?
Giving a delayed prescription, which is subsequently not required, can help to educate patients that in
most cases, RTIs are self-limiting and can be managed with symptomatic treatment
There is some evidence that delayed prescriptions educate patients about the limitations of using antibiotics for RTIs
and have a positive effect on future expectations about antibiotic prescribing for RTIs. A randomised controlled trial
involving 807 primary care patients with an acute lower RTI, investigated the effectiveness of three antibiotic prescribing
strategies (an immediate prescription for an antibiotic, a delayed prescription with advice to collect the prescription
from reception if symptoms did not resolve after 14 days or no offer of antibiotics), with or without an information leaflet
about antibiotics. Patients who received a delayed prescription were the least likely to believe in the effectiveness
of antibiotics for RTI (40%), compared to those who did not receive a prescription (47%) and those who received an immediate
prescription (75%).5 Receiving the information leaflet did not have any effect on this outcome, possibly
because all patients were also given verbal information about antibiotics.5
So, should a delayed antibiotic prescription be given to a patient with a RTI?
Yes…or no. It depends on the individual situation.
Taking all factors into consideration, it appears that patients can be effectively managed using a “no antibiotic” strategy
rather than a delayed antibiotic strategy, when the prescriber judges that an immediate antibiotic is not required. The
evidence suggests that not prescribing the patient an antibiotic initially, explaining why this decision has been made
and ensuring that patients understand to contact the practice if symptoms do not resolve, is likely to reduce antibiotic
use and result in similar clinical outcomes and patient satisfaction than using a delayed prescribing strategy. However,
in practice there will always be exceptions to this.
Delayed prescriptions are a good option for many patients who do not need antibiotics at the time of consultation but
may need them later. This strategy leads to far fewer prescriptions being filled than immediate prescription of antibiotics
and only a few more being filled than for patients not initially offered a prescription. Patients given a delayed antibiotic
prescription may have fewer complications of RTI, and satisfaction may be higher, compared with no antibiotic prescription
although neither of these has been proven with statistical significance, and satisfaction is largely dependent on effective
communication regardless of prescribing strategy. Giving a delayed prescription may have a positive effect on a patient’s
future expectations for receiving an antibiotic for a RTI, especially if their symptoms resolve without filling the prescription.
This may be a good strategy for “weaning” a patient from the idea that they always need an antibiotic.
There are several ways to offer a delayed prescription, e.g. collect from reception, post-dated prescription, phone
call – none has yet shown to be a better strategy than another. More research is needed to determine whether patients
who fill delayed prescriptions do so for the right reasons and how this might be improved. Delayed prescription strategies
will not suit all patients – some will benefit most from a face-to-face or telephone follow up, but combined with careful
history and examination, reassurance, symptom-control advice and clear instructions on when to fill the prescription,
it can be a good option.
For further discussion on prescribing antibiotics for RTIs, see our
Thank you to Dr Richard Everts, Specialist Physician, Medical Microbiologist and Infectious Disease Specialist,
Nelson and Marlborough DHB and Professor Bruce Arroll, Department of General Practice and Primary Healthcare,
University of Auckland for expert review of this article.
- Arroll B, Goodyear-Smith F, Thomas DR, et al. Delayed antibiotic prescriptions: what are the experiences and
attitudes of physicians and patients? J Fam Pract 2002;51:954–9.
- Spurling GKP, Del Mar CB, Dooley L, et al. Delayed antibiotics for respiratory infections. Cochrane Database
Syst Rev 2013;4:CD004417.
- Little P, Moore M, Kelly J, et al. Delayed antibiotic prescribing strategies for respiratory tract infections
in primary care: pragmatic, factorial, randomised controlled trial. BMJ 2014;348:g1606.
- Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce the use of antibiotics for the common cold? A single-blind
controlled trial. J Fam Pract 2002;51(4):324–8.
- Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower
respiratory tract infection. A randomised controlled trial. JAMA 2005;293:3029–35.
- Little P, Stuart B, Hobbs FDR, et al. Antibiotic prescription strategies for acute sore throat: a prospective
observational cohort study. Lancet Infect Dis 2014;14:213–9.
- Coenen S, Francis N, Kelly M, et al. Are patient views about antibiotics related to clinician perceptions, management
and outcome? A multi-country study in outpatients with acute cough. PLoS ONE 2013;8:e76691.
- Welschen I, Kuyvenhoven M, Hoes A, et al. Antibiotics for acute respiratory tract symptoms: patients’ expectations,
GPs’ management and patient satisfaction. Fam Pract 2004;21:234–7.